Bristol myers stock price target

BMY Stock Quote - Bristol-Myers Squibb Company Common ...

View today's stock price, news and analysis for Bristol-Myers Squibb Co. (BMY). Barron's also provides information on historical stock ratings, target prices,  How is Bristol-Myers Squibb forecast to perform in the next 1 to 3 years based on estimates from 13 analysts? 87.0%. Forecasted annual earnings growth  Stockopedia rates Bristol-Myers Squibb Co as a Conservative High Flyer . 6 brokers rate it as a 12m Forecast Rolling, Industry, Market Price to Book Value. 28 Oct 2019 Bristol-Myers Squibb Company is said to have a 12-month price target set at $60.38. That means that the stock has a strong potential to acquire  14 Aug 2019 Two drug stocks seeing bullish analyst attention are Horizon Pharma and Bristol- Myers Squibb. 9 Sep 2019 Societe Generale analyst Justin Smith raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $75.00 (from $66.00) while  4 Apr 2002 Bristol-Myers Squibb jolts Wall Street by saying that its sales and earnings for first Analysts had been expecting earnings of 56 cents a share.

Analysts Set Bristol-Myers Squibb Co (NYSE:BMY) Price ...

Bristol-Myers price target raised to $75 from $65 at Jefferies. Jefferies analyst Jeffrey Holford raised his price target for Bristol-Myers Squibb to $75 after increasing his estimates to reflect a faster than expected ramp for Opdivo monotherapy in lung cancer. Bristol-Myers Named a Bank of America Top Pick Amid ... Feb 06, 2020 · Bristol-Myers Squibb is tapped a Bank of America top pick amid coronavirus fallout. The New York pharma giant has a buy rating and $75 price target. Bristol-Myers Squibb Co (NYSE:BMY) price target lowered to ... Nov 27, 2018 · Analyst Ratings For Bristol-Myers Squibb Co (NYSE:BMY) Today, BMO Capital Markets lowered its price target on Bristol-Myers Squibb Co (NYSE:BMY) … The Fed May Have to Lower Rates Soon: Buy These Safe ... Holders of Bristol-Myers Squibb stock receive a 3.02% dividend. The $75 Merrill Lynch price target compares with the $72.30 consensus target, as well as the $59.58 closing price after almost a 4%

15 Wall Street analysts have issued ratings and price targets for Bristol-Myers Squibb in the last 12 months. Their average twelve-month price target is $64.33,  

Bristol-Myers price target raised to $75 from $65 at ... Bristol-Myers price target raised to $75 from $65 at Jefferies. Jefferies analyst Jeffrey Holford raised his price target for Bristol-Myers Squibb to $75 after increasing his estimates to reflect a faster than expected ramp for Opdivo monotherapy in lung cancer.

Bristol-Myers Squibb (NYSE:BMY) Upgraded to “Overweight ...

Jan 10, 2020 · In recent trading, shares of Bristol-Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $64.00, changing hands for $65.45/share. Bristol-Myers Squibb Company (BMY) Latest Stock News ...

Bristol-Myers (BMY) Stock Price Target Lowered at ...

Historical daily share price chart and data for Bristol-Myers Squibb since 1972 adjusted for splits. The latest closing stock price for Bristol-Myers Squibb as of April 03, 2020 is 55.53.. The all-time high Bristol-Myers Squibb stock closing price was 77.94 on October 28, 1999.; The Bristol-Myers Squibb 52-week high stock price is 68.34, which is 23.1% above the current share price.

Bristol-Myers Squibb Earnings: Time to Buy BMY Stock ... Oct 31, 2019 · Since my last article about Bristol-Myers Squibb , Bristol-Myers Squibb: Could BMY Stock Surge Higher?, the stock has risen from $50.22 to $57.96 at the moment of writing this article. This BMY Stock Quote - Bristol-Myers Squibb Company Common ... Stock quote for Bristol-Myers Squibb Company Common Stock Common Stock (BMY) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Bristol-Myers Squibb Company [BMY] Price Analysis: NYSE ... Mar 17, 2020 · However, the stock had a poor performance during the past 3 months, roughly losing -22.65%, while additionally gaining 2.30% during the last 12 months. Bristol-Myers Squibb Company is said to have a 12-month price target set at $73.00. That means that the stock has a strong potential to acquire 21.89% increase from the current trading price. Bristol-Myers Squibb Reaches Analyst Target Price - Nasdaq.com